[SCHEDULE 13G] MEI Pharma, Inc. SEC Filing

Rhea-AI Filing Summary

This Schedule 13G reports that Alexander Schornstein beneficially owns 2,115,000 shares of MEI Pharma common stock, representing 6.53% of the outstanding class based on 32,367,236 shares reported in the issuer's registration statement. The filing states that 1,890,000 shares are held directly and 225,000 shares are held by Camino Capital GmbH, for which Mr. Schornstein is the sole beneficial owner.

The report shows sole voting power over 2,115,000 shares and sole dispositive power over 2,065,000 shares, and includes a certification that the securities were not acquired to change or influence control of the issuer. The filer is identified as a citizen of Germany with a listed residence address.

Insights

Securities Analyst

TL;DR: 6.53% stake is a material disclosure; the filer reports substantial voting and dispositive power but disclaims intent to influence control.

The filing discloses a sizeable minority stake of 2,115,000 shares (6.53% of a 32,367,236-share base). For market participants, any holder above 5% is a notable ownership block that must be monitored for potential activism, coordination, or future trades. The disclosure that 225,000 shares are held through Camino Capital GmbH and that the filer retains sole voting authority clarifies the chain of control. Impact: Impactful (material ownership disclosure).

Corporate Governance Expert

TL;DR: Concentrated sole voting and dispositive power reported; the statement includes an explicit certification against control intent.

The report shows concentrated governance authority with sole voting power over 2,115,000 shares and sole dispositive power over 2,065,000 shares, while disclosing an affiliated holding (Camino Capital GmbH) for 225,000 shares. The filing also contains the required certification that the shares were not acquired to effect a change in control. From a governance perspective, the explicit ownership and power metrics are material for board and shareholder monitoring. Impact: Impactful (material disclosure).

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

MEI Pharma, Inc.

(Name of Issuer)

Common Stock, par value $0.001

(Title of Class of Securities)

55279B301

(CUSIP Number)

08/11/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 55279B301

1

Names of Reporting Persons

Alexander Schornstein

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,115,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,115,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,115,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.53 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MEI Pharma, Inc.
(b)	Address of issuer's principal executive offices: 9920 Pacific Heights Blvd., Suite 150 San Diego, CA, 92121
Item 2.
(a)	Name of person filing: Alexander Schornstein
(b)	Address or principal business office or, if none, residence: Kaiser-Friedrich-Allee 2, 52074 Aachen Germany 004915142314669
(c)	Citizenship: Germany
(d)	Title of class of securities: Common Stock, par value $0.001
(e)	CUSIP No.: 55279B301
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,115,000 (1) (1) Includes 1,890,000 shares of Common Stock held by Alexander Schornstein and 225,000 shares of Common Stock held by Camino Capital GmbH, in which Alexander Schornstein is the sole beneficial owner and has sole voting power.
(b)	Percent of class: 6.53% (2) (2) Based upon 32,367,236 shares of common stock of the Issuer issued and outstanding, as stated in the Company's registration statement on Form S-3 filed with the United State Securities and Exchange Commission on August 6, 2025, prior to the completion of the offering contemplated by the registration statement.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,115,000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,065,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alexander Schornstein

Signature:	/s/ Alexander Schornstein
Name/Title:	Alexander Schornstein
Date:	08/12/2025